University of Tennessee, Knoxville

TRACE: Tennessee Research and Creative
Exchange
Masters Theses

Graduate School

5-2002

CIS-acting requirements for bovine coronavirus defectiveinterfering RNA replication
Cary Gay Brown
University of Tennessee

Follow this and additional works at: https://trace.tennessee.edu/utk_gradthes

Recommended Citation
Brown, Cary Gay, "CIS-acting requirements for bovine coronavirus defective-interfering RNA replication. "
Master's Thesis, University of Tennessee, 2002.
https://trace.tennessee.edu/utk_gradthes/5892

This Thesis is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and
Creative Exchange. It has been accepted for inclusion in Masters Theses by an authorized administrator of TRACE:
Tennessee Research and Creative Exchange. For more information, please contact trace@utk.edu.

To the Graduate Council:
I am submitting herewith a thesis written by Cary Gay Brown entitled "CIS-acting requirements
for bovine coronavirus defective-interfering RNA replication." I have examined the final electronic
copy of this thesis for form and content and recommend that it be accepted in partial fulfillment
of the requirements for the degree of Master of Science, with a major in Microbiology.
David A. Brian, Major Professor
We have read this thesis and recommend its acceptance:
Accepted for the Council:
Carolyn R. Hodges
Vice Provost and Dean of the Graduate School
(Original signatures are on file with official student records.)

To the Graduate Council:
I am submitting herewith a thesis written by Cary Gay Brown entitled "Cis-Acting
Requirements for Bovine Coronavirus Defective-Interfering RNA Replication." I have
examined the final paper copy of this thesis for form and content and recommend that it
be accepts in partial fulfillment of the requirements for the degree of Master of Science,
with a major in Microbiology.

Dr. David A. Brian, Major Professor

We have read this thesis
and recommend its acceptance:

Vice Provost and De
Graduate Studies

o

C/S-ACTING REQUIREMENTS FOR BOVINE
CORONAVIRUS DEFECTIVE-INTERFERING
RNA REPLICATION

A Thesis
Presented for the
Master of Science
Degree
The University of Tennessee, Knoxville

Cary Gay Brown
May 2002

ACKNOWLEDGEMENTS
There are a number ofpeople I am grateful to for their guidance and friendship
while attending the University ofTennessee. I wish to abundantly thank Dr. David
Brian, my mentor, for his guidance, support and expertise from the beginning ofmy
project, Dr. Savithra Senanayake for my early laboratory training, Dr. Kimberley Nixon
for her guidance and enthusiasm during my attendance at UT, Dr. Hung Yi Wu for the
excitement for science he shares with everyone and the rest ofmy lab mates: Sharmila
Raman and Gwyn Williams.
I wish to express additional thanks to my committee members Dr. Jeffrey Becker
and Dr. Potgieter for their interest and enthusiasm for my project.
Thanks to my husband, Chris, and my family for constant support and attempted
understanding ofvirology and molecular biology.

ii

ABSTRACT
A naturally-occurring 2.2kb defective interfering (DI) RNA of bovine coronavirus
(BCoV) has been cloned and is being used as a minireplicon to characterize the cis-acting
elements in its structure for DI RNA replication. The DI RNA is comprised of the two
ends of the virus genome, the 5'-most 498-nt and the 3'-1803-nt including a poly(A) tail
of 68-nt, and it replicates in the presence of the parent helpervirus. Within the DI RNA is
a single open reading frame (ORF) resulting from the fusion of 288-nt of gene 1a and the
entire 1348-nt N gene. A 30-nt in-frame reporter has been inserted at base position 1098
to enable quantitative Northern analyses of DI RNA replication. The hypothesis that cis
acting elements for replication lie within the 288-nt partial ORF 1a region was suggested
by (1) the presence of a similar region in all coronavirus DI RNAs described to date, and
(2) a previous experiment which showed that DI RNA replication was blocked by
conversion of the ORF 1a start codon to a non-start codon. To test this hypothesis, the
study described here was undertaken to map and characterize the cis-acting element(s)
within the partial ORF l a region. For this, 5 prime-ward in-frame deletions of the 288-nt
gene 1 a region were made from its 3' terminus and transcripts were tested for replication.
It was learned that 3'-terminal, in-frame deletions of 102 nt (encoding aa 63-96) but not
141 nt (encoding aa 50-96), were tolerated for DI RNA replication. Further analysis of
the remaining 186-nt revealed the presence of two cis-acting elements. The first is a
protein encoded by the ORF. This was learned from frameshift experiments that changed
the identity of 12 and 26 amino acid stretches, respectively, while maintaining a fused
iii

ORF. These changes resulted in the loss of DI RNA replication. The second cis-acting
element is a higher-order RNA structure. This was learned by testing a phylogenetically
conserved, computer (mfo/d)-predicted 36-nt RNA stem-loop located between nt 308 and
343. Mutations predicted to disrupt the stem while maintaining the wild-type amino acid
sequence destroyed replicating ability whereas compensatory mutations restoring the
secondary structure also restored replicating ability. This study is the first to identify cis
acting elements for coronavirus RNA replication mapping within the ORF 1a region of
the genome. It is also the first study to show any function for coronavirus gene 1a. It is
predicted that the cis-acting elements identified here for DI RNA replication will have the
same function in the full-length bovine coronavirus genome.
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CHAPTER I.
LITERATURE REVIEW ON C/S-ACTING SIGNALS IN BOVINE
CORONAVIRUS DEFECTIVE INTERFERING RNA REPLICATION

INTRODUCTION
Bovine coronavirus (BCoV) is an enveloped, positive-sense, single-stranded,
RNA virus with a genome length of 31, 030 bases (Nixon and Brian, unpublished). As
with other positive-strand RNA viruses, BCoV is believed to replicate in membrane
associated replication complexes (Dennis and Brian, 1982; Brayton et al., 1984; Tung et
al., 1992; Sethna and Brian, 1997; Sims et al., 2000; Bost et al., 2001). Members of the

family Coronaviridae in the order Nidovirales possess the largest known RNA genomes.
In addition to size, another defining characteristic of Coronaviruses is a unique
transcription strategy in which an identical 5'-leader sequence of approximately 65 nts,
encoded only at the 5'-terminus of the genome, is placed onto the 5'-end of each species
of a 3'-coterminal, nested set of subgenomic (sg) mRNAs (BCoV generates seven sg
mRNAs). The largest mRNA is identical to the genome and the smallest is less than 2 kb
in length. The mRNAs function monocistronically as only the 5'-most open reading
frame (ORF) in each case is translated to give rise to viral structural or nonstructural
proteins. Translation of the genome must occur before RNA synthesis can begin. ORF
la and lb overlap to comprise approximately two-thirds of the coronavirus genome and
this region encodes the enzymes responsible for RNA replication. ORF 1a is translated
as a single polyprotein of approximately 500 kDa which is then proteolytically processed
by viral-encoded proteinases. Translation of ORF lb gives rise to a polyprotein of
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approximately 800 kDa via ribosomal frameshifting at a slippery sequence and
pseudoknot located at the overlap region between ORF la and lb. It is also
proteolytically processed to produce proteins that include the RNA-dependent RNA
polymerase and helicase required for RNA synthesis (Lai and Cavanagh, 1997); (Brierley
et al., 1987), an estimated 16 functional proteins in all based on predicted protease

cleavage sites.
Although full-length cDNA clones have recently been obtained for transmissible
gastroenteritis virus (Almazan et al. , 2000; Yount et al., 2000) and human coronavirus
229E (Thiel et al., 2001), a full-length cDNA clone does not yet exist for BCoV.
Therefore, insight into the cis-acting signals responsible for BCoV genome replication is
attainable at this time only through studies on defective interfering (DI) RNA
minireplicons. A minireplicon of the 2.2kb, naturally-occurring BCoV DI RNA, named
pDrep1, has been obtained in our laboratory and is being used to investigate the cis
acting signals required for its replication (Fig.1-1) (Chang et al., 1994). This study
examines specifically the cis-acting elements residing within the 288-nt partial ORF 1a
region of the BCoV DI RNA. The partial ORF la region is the 5'-most portion of the DI
RNA-encoded ORF, and it is fused in-frame to the full-length N gene. Interestingly, all
coronavirus DI RNAs described to date encode some portion of the 5'-end of ORF la
(Brian and Spaan, 1997). To date, no cis-acting replication elements have been described
within ORF 1a.

BACKGROUND ON BCoV DI RNA REPLICATION
Use of defective interfering RNA to identify cis-acting replication elements.
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Figure 1-1. Schematic depiction of the BCoV genome and subgenome-size
molecules used to study RNA replication. A. DI RNA is the naturally-occurring 2,133
nt-long BCoV defective-interfering RNA that is intermediate in size between mRNA
7( encoding the N protein) and mRNA 6 (encoding the M protein). pDrep1 is the cloned
DI RNA with an in-frame 30-nt reporter sequence cloned into the Bgffi site and used for
quantitative Northern analyses in replication studies. Depicted is the T7-polymerase
generated transcript of pDrep1. pNrep2 is a clone of mRNA 7 containing the same 30-nt
reporter as pDrep1. Transcripts of pNrep2, which do not replicate after transfection into
helper virus-infected cells, differ from transcripts of pDrep1, which do replicate, by 421
nts (Chang et al., 1994). The 5'-tenninal 65 nt leader is depicted as a filled rectangle. B.
Schematic depiction of the 421-nt difference between replicating pDrep1 and
nonreplicating pNrep2.
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Historically, defective RNA (D RNA) and defective interfering RNA (DI RNA) replicons
have been the experimental workhorses for identifying cis-acting replication elements in
RNA viruses (Holland, 1985). D RNA and DI RNA are extensively deleted derivatives of
the full-length virus genome. D RNAs and DI RNAs arise in nature as the result of
replicase error in which the RNA-dependant RNA polymerase (RdRp) jumps from one
RNA template to another, possibly during RNA replication or nonhomologous
recombination {Lai and Cavanagh, 1997; Furuya et al., 1993; Lai, 1992). The resulting
replicons usually lack an independent ability to replicate since all or some of the RdRp is
commonly missing and must, therefore, be co-infected with helper virus to have access to
the missing genomic functions. Additionally, DI RNA "interferes" with the replication of
helper virus, whereas D RNA does not. The trans-acting RdRp is usually, but not
always, the helper component supplied by the helper virus (Holland, 1985). Since D
RNA and DI RNA genomes are minireplicons, cis-acting elements required for
replication and packaging must be present within their sequence.

Currently known cis-acting requirements for BCoV DI RNA.

Previous work by Chang et al. (1994) led to the cloning of pDrepl. To create
pDrepl, a 30-nt reporter sequence was inserted at the BgilI site within the N gene at DI
RNA nt position 1098. This insert has been extensively used for the quantitation of
pDrep1 plus and minus-strand molecules by Northern analysis in replication assays
(Chang et al., 1994; Chang et al., 1996; Chang and Brian, 1996; Krishnan, R. et al.,
1996; Ozdarendeli, A. et al., 2001). pDrep1 is 2.2kb in length and contains the genomic
210-nt 5'-UTR (that includes the 65-nt genomic leader), the 288-nt 5'-terminal portion of
4

gene l a fused in-frame to the 1348-nt full-length N gene, a 288-nt 3'-UTR, and a 68-nt
poly(A) tail. When in vitro-synthesized transcripts of pDrep1 are transfected into helper
virus infected cells, plus-strand accumulation, indicative of DI RNA replication, is
measured by Northern analysis. Packaging and passaging of progeny of pDrep1 with the
helper virus are also observed and routinely monitored.
Much work has been done to determine the cis-acting elements required for
BCoV DI RNA replication. With the use of pDrepl , cis-acting signals that have been
identified to date include the genomic leader sequence, RNA stem loops I, II, III, and IV
all within the 210-nt 5'-UTR, a translational requirement for the DI RNA-encoded fusion
ORF, the N protein sequence, an RNA pseudoknot within the 3'-UTR and a poly(A) tail.
Enzyme structure probing of the RNA secondary structure suggested that the leader
contains all of stem loop I and part of stem-loop II as predicted by computer-assisted
RNA foldings (Chang et al., 1994). Mutagenesis of leader sequence within stems I and II
resulted in rapid reversion of leader to wild-type sequence (Chang et al., 1994; Chang et
al., 1996). Further downstream within the 210-nt 5'-UTR are computer (mfold)-predicted

stem-loop III and stem-loop IV, located at nts 85 to 128 and nts 186 to 215, respectively.
Enzyme structure probing has verified the existence of each of these and mutagenesis
studies have revealed that maintenance of both is required for DI RNA replication
(Raman, unpublished). Preliminary gel shift assays, furthermore, revealed that cellular
and/or viral proteins bind these structures (Raman, unpublished). Within the 3'-UTR is a
pseudoknot structure proposed to function either as a translational enhancer or as an
element binding proteins in the formation of a replication complex (Williams et al.,
1999). The 3'-terminal poly(A) tail has also been implicated as a cis-acting element for
5

DI RNA replication (Senanayake, unpublished; Spagnolo and Hogue, 2000). The
poly(A) tail is hypothesized to function by binding the cellular poly(A) binding protein
and facilitating translation through a circularization mechanism (Spagnolo and Hogue,
2000). In addition, it was learned that the single, continuous la-N ORF present in BCoV
DI RNA must remain open and translatable for replication (Chang and Brian, 1996).
Premature translation termination resulting from frameshift mutations led to loss of DI
RNA replication. Additionally, the N protein sequence appeared to be a cis-acting
element. 3'-terminal N gene sequence truncations of greater than 15% were not tolerated
for DI RNA replication, nor was substitution of N by a naturally occurring I protein ORF
(occurring within N gene sequence but in an alternate reading frame). The exogenous
CAT gene could also not be substituted for N (Chang and Brian, 1996).

Rationale for the study of the 288-nt ORF la region in DI RNA replication.

Three observations led us to seek the identity of cis-acting elements within the
ORF l a region. (1) This region of ORF la is present in all coronavirus DI RNAs
described to date (reviewed in Brian and Spaan, 1997). (2) Stop codons preventing
translation of the partial ORF 1a region also prevented DI RNA replication (Chang and
Brian, 1996). (3) BCoV subgenomic mRNA 7 postulated to be a replicon (Sethna et al.,
1989), but missing 133-nt of the genomic 5'-UTR and the 288-nt ORF la region, failed
to replicate following transfection into helper virus infected cells (Fig.1-1; Chang et al.,
1994).
The 288-nt ORF la region encodes the first 96 aa of p28 (280 aa total), the 5'
most cleavage product of ORF 1a as described for mouse hepatitis coronavirus (Denison
6

and Perlman, 1986; Dong et al., 1995). This cleavage site appears nearly identical in
BCoV (Nixon and Brian, unpublished). While the function of MHV p28 remains
unknown, biochemical evidence of its localization by cell fractionation shows
cofractionation of p28 with newly synthesized RNA suggesting it may have a role in
RNA synthesis or in formation or maintenance of membranous replication complexes
(Sims et al., 2000). RNA synthesis in membranous replication complexes is well
documented in plus-stranded RNA viruses (Dennis and Brian, 1982; Brayton et al., 1984;
Tung et al., 1992; Sethna and Brian, 1997; Hansen et al., 1998; Shi et al., 1999; Denison
et al. 1999; van der Meer et al., 1999; Sims et al., 2000; Bost et al., 2001). These

observations further suggest a role for the complete p28 or a portion of it.
The 288-nt partial ORF la region has not been examined as a potential site for
cis-acting elements for RNA replication. Therefore, the following questions are addressed
in this chapter. Is the partial ORF la region required in cis for DI RNA replication in
BCoV? If so, might it function to provide a cis-acting protein product, or the presence of
cis-acting higher-order RNA structural elements, or both?
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CHAPTER II.
TRANSLATION OF THE PARTIAL ORF lA REGION IS A C/S-ACTING
REQUIREMENT FOR DEFECTIVE-INTERFERING RNA REPLICATION IN
BOVINE CORONAVIRUS

INTRODUCTION
Translation of the virus genome is a required first step in the replication of all
plus-strand RNA viruses. This is necessary since the viral RdRp is not a structural
component of the virus and needs to be generated for genome replication. In addition to
this requirement, however, there has also been found, for a number of plus-strand viruses,
a curious cis-acting requirement for translation in genome replication. Translation as a
cis-acting requirement for replication has been shown experimentally for defective RNA
(D RNA) replication ofpoliovirus (Novak and Kirkegaard, 1994), turnip yellow mosaic
virus (TYMV) (Weiland and Dreher, 1993), mouse hepatitis coronavirus A59 (MHV
A59) (de Groot et al., 1992) and BCoV (Chang and Brian, 1996) and more recently in
Kunjin virus (Khromykh et al., 1999). Required translation of portions of D RNA are
postulated to be due to cis-action of a protein product or due to required ribosomal
passage in cis (Novak and Kirkegaard, 1994).
By using poliovirus helper virus and poliovirus defective RNAs in an amber
codon suppressing cell line in comparison with a nonsuppressing cell line it was
demonstrated that important regions like the 3Dpol can be complemented in trans.
However, translation of the cis required region, a region that remains to have its borders
determined, must occur in cis. While the mechanism for translation as a cis-requirement
8

for RNA replication remains unknown, it has been shown not to be due to an influence on
RNA stability or on a constant supply of viral proteins to nascent RNA strands (Novak
and Kirkegaard, 1994).
The requirement for translation in cis has also been found for the Kunjin virus ns5
gene. The C-terminal region of the ns5 gene product contains several conserved RdRp
motifs of various postulated functions (O'Reilly et al., 1998; Khromykh, et al., 1999),
while the N-terminal region contains two conserved methyltransferase domains (Koonin,
1993; Khromykh, et al., 1999). Complementation analysis with this flavivirus showed
that the 3'-terminal half of the NS5 coding region of a defective RNA could be
effectively complemented in trans, and RNA replication was rescued in persistently
infected cells. However, frameshift mutations at the beginning ofNS5 and deletions into
the 5'-terminal half of the NS5 coding region resulted in loss of replication due to
inability of N-terminal NS5 to be trans-complemented. These results suggested that only
when the N-terminus ofNS5 is translated in cis can RNA be recognized and efficiently
amplified (Khromykh et al., 1999).
The requirement for translation in cis has been found in turnip yellow mosaic
virus for which there is a concurrent processing of the 206-kDa protein into p70 and p150
(Weiland and Dreher, 1993). These proteins contain the RdRp and helicase motifs,
respectively. Translation in cis in this virus is thought to aid in the assembly of
replication proteins preferentially and efficiently into a replication initiation complex on
that same RNA molecule. Channeling cis-acting proteins for function on same RNA
molecules for complex formation is predicted to aid the switch between
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mRNA/translation role to template role for minus strand synthesis (Weiland and Dreher,
1993).
Dependence on translation in cis for replication of coronavirus DI RNAs has been
observed, but the degree of dependence is not the same for all molecules. For DI MIDI
and DISSE ofMHV, for example, dependence on translation in cis is not strict, and these
molecules are characterized as having a preference for translation in cis (Kim et al.,
1993). That is, molecules without a contiguous open reading frame will replicate, but
lose out over time to replicons that gain a contiguous open reading frame. By contrast,
the DI RNA isolated from BCoV in our studies as characterized by the pDrepl construct
has a strict requirement for the contiguous open reading frame extending throughout
approximately 70% of the N portion of the contgious ORF (Chang and Brian, 1996).
Blockage by insertion of termination codons within the partial ORF 1a or N ORF
anywhere within the first 70% of the N sequence, kills replication (Chang and Brian,
1996). Moreover, the quality of the N gene product appears to be important since a frame
shifting mutation leading to the expression of I in place of N does not support replication.
Thus, for the BCoV DI RNA there is a strict requirement for translation in cis for
replication.
A preliminary study has suggested that in BCoV pDrep1 the ORF 1a region may
require translation in cis for replication (Chang and Brian, 1996). Conceptually, this is an
important issue since BCoV mRNAs, postulated to be replicons (Sethna et al., 1989), fail
to replicate (Chang et al., 1994). Cloned BCoV mRNA 7 (pNrep2) is identical to pDrepl
except for 421-nt of contiguous 5' proximal sequence (Fig.1-1). The partial ORF 1a
region is contained within the 421-nt sequence. To investigate the cis-acting elements
10

associated with the ORF l a requirement for DI RNA replication, two sets of experiments
were performed. First, a construct was synthesized in which the partial ORF 1a region
was precisely deleted while the full-length 210-nt 5'-UTR and full-length N gene were
maintained. Second, mutations introducing stop codons at various internal locations
throughout the ORF 1a sequence were made in order to prematurely terminate
translation. Both sets of constructs were tested for DI RNA replication in the in vivo
replication assay. Loss of replication in both sets of experiments suggested that the
process of translation for ORF 1a is, indeed, required in cis for BCoV DI RNA
replication. To determine if the quality of the ORF l a gene product is also required, two
frameshift constructs were generated that created different amino acid sequences for
stretches of 12 and 26 amino acids, and these were tested in the in vivo replication assay.
The results indicate that the quality of the partial ORF 1a gene product is a cis-acting
requirement for BCoV DI RNA replication.
MATERIALS AND METHODS

Virus and cells.

Bovine coronavirus Mebus strain was plaque-purified three times and used as
helper virus in all replication experiments. Stock preparations had an infectious titer of 1
x 107 PFU/ml. Human rectal tumor cell line, HRT-18, was used in all experiments. Cells
were grown as monolayers in Dulbecco' s modified Eagle medium containing 10% fetal
calf serum (Atlanta Biological, Atlanta, GA) in 35 mm2 plates.

11

Construction of plasmids.
.

.

.

.

Using the indicated DNA template and respective oligonucleotides designated
below and in Table 2-1, the following constructs were made via overlap PCR
mutagenesis, followed by recombination PCR. All PCR mutagenesis reactions were
performed under the same conditions: lX Pfu Turbo enzyme buffer, 0.2mM dNTPs, 25ng
of respective DNA template, 0.5µM of each of respective primer (+) and primer (-) and
l.25U (0.5µ1) Pfu Turbo enzyme (Stratagene), plus water for a final volume of 50µ1.
Initial denaturation was performed at 94° C for 2 minutes. Denaturation, annealing and
extension conditions were 94 ° C, 55 ° C, and 72 ° C, respectively. All temperatures were
maintained for 1 minute each for a total of 13 cycles. Final renaturation was performed
at 72 ° C for 10 minutes.
Recombination PCR was performed using the two products generated during PCR
mutagenesis. In preparation for recombination PCR, PCR products were either excised
from a TAE gel and genecleaned or directly removed via pipette from the TBE gel. For
maximal DNA production, due to a need for further molecular manipulations after
recombination PCR, 3-4 50-µ1 (total 150-200 µI) recombination reactions were prepared.
Denaturation, annealing, and extension temperatures were 94 ° C, 60 ° C, and 72 ° C,
respectively, for 2 minutes each in 17 total cycles. Final renaturation was performed at
72 ° C for 10 minutes.
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Plasmid constructs were all modifications of pDrep1 (Chang and Brian, 1996)
except as noted. For each, mutated regions were confirmed by sequencing at the UTK
Molecular Biology Resource Facility.
p77Drep 1 was generated by PCR overlap mutagenesis. For this, the gel-purified
1197-nucleotide (nt) PCR product from a pDrepl-templated reaction with primers
PGEM3Zf(-) 2097 and 77LDI(+) and the gel-purified 782-nt PCR product from a
reaction with D1211-232(-) and oligo 2(+) were created. Recombination PCR with
PGEM3Z(-) 2097 and oligo 2(+) formed a 2095-nt product, from which the 1158-nt Ndel
fragment was used to replace the analogous region in pDrep1.
p210Nrep was created by digesting pNrep2 (Chang et al. , 1994) with Bg/11,
creating a 754-nt fragment and replacing the analogous region in Bg/11- digested pDrepl.
Similarly, p226AAA ➔ UAA was generated by PCR overlap mutagenesis using
the 957-nt fragment from a reaction with primer PGEM3Z 2477(-) and laSTOP226(+)
and the 777-nt fragment from a reaction with primers 1aSTOP226(-) and oligo 2(+).
Recombination PCR with PGEM3Z 2477(-) and oligo 2(+) yielded a 1765-nt fragment,
of which the 443-nt Hpal-Xbal fragment was used to replace the analogous region in
pDrepl.
p268AUG➔ UGA was synthesized identically to pla226AAA ➔ UAA except
PCR overlap mutagenesis replaced primers laSTOP226(+) and laSTOP226(-) with
laSTOP268(+) and 1aSTOP268(-), respectively.
p211AUG ➔ UGA was generated by PCR overlap mutagenesis using the 941-nt
fragment from a reaction with primers PGEM3Z 2477(-) and 5'STOP(+) and the 793-nt
fragment from a reaction with 5'STOP(-) and oligo 2(+). Recombination PCR with
13

PGEM3Z 2477(-) and oligo 2(+) yielded a 1765-nt product of which the 443-nt Hpal
Xbal fragment was used to replace the analogous region in pDrep1.

p468AUA➔ AM was synthesized by linearizing plasmid DNAwith Ndel. Two
nucleotides were deleted by mung bean nuclease digestion and religated.
pFS@223 was generated by two rounds of PCR overlap mutagenesis first using
the 957-nt fragment from a reaction with primers FS@223(+) and PGEM3Z 2477(-) and
the778-nt fragment from FS@223(-) and oligo 2(+). Recombinant PCR with PGEM3Z
2477(-) and oligo 2(+) yielded a 1715-nt fragment from which the 1158-nt Ndel fragment
was used to replace the analogous region in pDrep1. A second round of PCR
mutagenesis using the above pFS@223 plasmid as template restored the proper reading
frame by recombining the 1039-nt IF@304(+) and PGEM3Z 2477(-) and the 699-nt
IF@304(-) and oligo 2(+) fragments. The 1716-nt recombinant product yielded a 1158nt fragment after Ndel digestion that was used to replace the analogous region in
pFS@223.
pFS@270was generated in an identical manner using reactions with primers
FS@270(+) with PGEM3Z 2477(-) and FS@270(-) with oligo 2(+). The corresponding
products1003-nt and 732-nt were used in recombination PCR with PGEM3Z 2477(-) and
oligo 2(+).

In vitro transcription.

Transcription of plasmid constructs including p211AUG ➔ UGA,
p211AUG ➔ UUG, p226AAA ➔ UAA, p268AUG ➔ UGA, and p468AUA ➔ AM was
performed using T7 RNA polymerase as recommended by Promega. For this, 10µg of
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Mlul linearized plasmid DNA was blunt-ended with mung-bean nuclease and 5µg of

linearized, blunt-ended DNA was transcribed with 40 units (U) of T7 RNA polymerase
(Promega, Madison, WI) in a 100µ1 reaction which included supplied transcription
buffer, lOµg bovine serum albumin (BSA), lOmM DTT, lO0U RNasin and rNTPs. The
transcription reaction mix was then treated with SU ofRNase-free DNase (Promega,
Madison, WI) and newly synthesized RNA was chromatographed through a Biospin 6
column (Bio-Rad, Melville, NY) and quantitated by spectroscopy.

Assay for replication: transfection and Northern blot analysis.

HRT cells grown to 50-80% confluency (~106 cells) in 35 mm2 dishes were
infected with BCV at a multiplicity of 10 PFU per cell by incubating cells with the
inoculum at 37° C plus 5% CO2 for lh. Cells were refed with 2ml Dulbecco's modified
Eagle's medium containing 10% fetal bovine serum and incubated at 37° C plus 5% CO2
for 1-1.Sh.
For transfection, each plate of cells was rinsed three times with lX phosphate
buffered saline (PBS). Cells were treated for 10 min at room temperature with 10µg
Lipofectin (Invitrogen Gibco-BRL, Carlsbad, CA), lµg transcript and varying amounts of
I X PBS to make a total volume of 200µ1. Cells were rinsed with 2ml of growth medium
without fetal bovine serum. Cells were then incubated at 37° C with 2ml Dulbecco's
modified Eagle medium containing 10% fetal bovine serum until cytoplasmic RNA
extraction was performed at 1 h, 24 h, and 48 h post transfection (hpt).
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For serial passage of progeny virus, cell supernatant was harvested at 48 h post
infection and 500µ1 was used to directly infect cells at 50-80% confluency in 35-mm2
dishes. Cytoplasmic RNA was extracted at 48 hours post infection for analysis.
For cell harvest and RNA extraction, cells were washed three times with Earle's
balanced salt solution at the designated time points. With cells on ice, 500µ1 of lysis
buffer (lOmM Tris buffer, lOmM NaCl, 5mM MgCh , and 1% NP40) were added to each
plate. Cell debris was pelleted at 9400 rpm for 4 min at 4° C and the remaining RNA in
aqueous solution was treated with proteinase K for 30 minutes at 37° C. After phenol
chloroform extraction, RNA was precipitated from the aqueous phase by adding two
volumes of absolute ethanol. Precipitated RNA was stored at -20 ° C.
One 35-mm dish yielded approximately lOµg of RNA. For Northern analysis,
2.5µg of RNA was loaded per well in a 1% formaldehyde-containing, agarose gel. RNA
samples for electrophoresis were prepared by pelleting precipitate from 500µ1 of the
RNA-ethanol suspension. The RNA pellet was resuspended in a sample mixture
composed of 1.9µ1 lOX morpholinopropane sulfonic acid (MOPS) buffer, 3.3µ1 37%
formaldehyde, 9.3µ1 100% foramide, and water. Loading buffer was added after samples
were heated for 10 min at 65° C. lng of transcript for each construct was prepared and
loaded as a size marker. The gel was loaded, covered in a lX MOPS-formaldehyde
buffer, and electrophoresed at 150 V for 3.5-4.5 h.

32P-radiolabeled

nucleotide probes

were prepared as described (Sethna et al. 1989). The specific activities of the probes
ranged from lx106 to 4x107 cpm/pmole and film exposure times ranged from 24 hours to
7 days.
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Electrophoresed RNA was blotted onto nylon membrane (Amersham Biosciences,
Piscataway, NJ) by vacuum transfer in 20X SSC buffer. After a 3h transfer, RNA was
crosslinked on the �embrane by ultraviolet radiation. The membrane was prehybridized
in 10ml prehybridization buffer for 6+ h at 55 ° C in a rotisserie oven. 32P-end labeled
oligonucleotide TGEV 8 (+) was used as the probe for Northern analysis (Hofmann et al.,
1990). The membranes were washed in 2X SSC containing 10% SDS for 20 min at room
temperature and 25 min at 55° C before drying and exposure to film.

Reverse transcription PCR and sequencing to identify revertant molecules.

The construct p211AUG ➔ UUG was cDNA cloned using oligonucleotide TGEV
#8b for reverse transcription. Then, single-stranded cDNA was amplified by using
primers TGEV #8(+) and leader (-). Gel-purified products were sequenced at the UTK
Molecular Biology Resource Facility.

In vitro translation.

In vitro translation of transcripts were performed in wheat germ lysate and rabbit
reticulocyte lysate, as specified by the manufacturer (Promega, Madison, WI). For
translation in the wheat germ extract, 50µ1 reactions containing 100U RNasin, 1.17mM
potassium acetate, 0.02 mM amino acid solution minus methionine, lmCi/ml of 35 S
methionine (ICN), 0.3 to lµg RNA transcript, and 25µ1 wheat germ extract were used.
Incubation was at 25 ° C for 1h.
For translation in rabbit reticulocyte lysate, 50µ1 reactions containing 35µ1 of
nuclease-treated rabbit reticulocyte lysate, l00U RNasin, 0.02 mM amino acid mixture
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minus methionine, 0.3 to lµg RNA transcript, and lmCi/ml of

35

S methionine were

used. Incubations were at 30° C for 1h. Both wheat germ and rabbit reticulocyte
reactions were stopped by the addition of an equal volume of 2X Laemmli standard
treatment buffer (STB) (lX STB contains 0.0625M Tris buffer, pH 6.5, 2% SDS, 10%
glycerol and 10µg bromophenol blue). Products were analyzed on an 8% SDS
polyacrylimide gel according to the procedure of Laemmli (1970).

Synthetic oligonucleotides.

Oligonucleotides used in this study are described in Table 2-1. Oligonucleotides
were synthesized by Sigma-Genosys {The Woodlands, TX) or Invitrogen Gibco-BRL
(Carlsbad, CA).
RESULTS

Both the 210-nt genomic 5'-UTR and the 288-nt partial ORF la regions harbor cis
acting elements for BCo V DI RNA replication.

To test whether the 288-nt partial ORF 1a region harbors cis-acting elements for
DI RNA replication, two constructs were generated. The first, called p77Drep, was
identical to the replicating pDrepl (Fig. 1-1) except that the 210-nt genomic 5'-UTR in
pDreplwas replaced with the 77-nt 5'-UTR from mRNA 7. The second, called
p210Nrep2, was identical to pNrep2 (Fig. 1-1) except that the 77-nt 5'-UTR was replaced
with the 210-nt genomic 5'-UTR. These constructs are illustrated in Fig. 2-1.
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Table 2-1. Oligonucleotides used in this study.

-

\0

Oligonucleotide•
FS@223(+)
FS@223(-)
FS@270(+)
FS@270(-)
IF@304(+)
IF@304(-)
laSTOP270(+)
laSTOP270(-)
laSTOP226(+)
laSTOP226(-)
5' STOP(-)
5' STOP(+)
DM(+)
DM(-)
77LDI(+)
D1211-232(-)
PGEM3Z 2097(-)
PGEM3Z 2477(-)
Oligo 2(+)
Leader (-)
TGEV#8(+)
TGEV#8bt!:l
a Oligonucleotide binds to

Sequence6· c
GACCGTATTTCT�rCATCCTCG
CGAAGATC�CAAATACGGTC
GCGTCCTC�cTCCATGG
CCATGGATdoTTGAGGACGC
CCTCTGAACTACTGAGGGTTATC
OAT AACCCTCAGTAGTTCAGAGG
CCTCAAACTACCATGGAAATTC
GAATTTCCATGGTAGTTTGAGG
GACCGTATTAGTTGATCTTC
GAAGATCAACTAATACGGTC
CATAGGTCACATAGTCGAAGATC
GATCTTCGAI.QTGACCTATG
GTTGATCTTCGACAATGTGACC
GGTCACAITGTCGAAGATCAA
GAGCGATTTGCGTGCGTGCATCCCGC
CGTATTTGTTGATCTTCGACAT/CCTTAAAGTTTAG
AGGGCGACACGGAAATGTTG
GGCATCAGAGCAGATTGTACTG
GTCCCGATCGAGAATGTCAGCCGGGG
GAGCGATTTGCGTGCGTGCATCCCGC
CATGGCACCATCCTTGGCAACCCAGA
CATGGCACCATCCTTGGCA

Binding region (nt position,3
215-235
215-235
262-281
262-281
295-316
295-316
256-277
256-277
216-23 5
216-235
200-222
200-219
204-225
204-225
7-32
65-74/211-232
2097-2116
2477-2498
968-993
7-32
1098-1123
1105-1123

either plus-sense RNA, as indicated by (+), or to minus-sense RNA, as indicated by (-).
b Underlined bases indicate differences from genomic sequence.
c Bold type bases indicate additional bases added to genomic sequence.
d Numbers correspond to pDrepl + strand sequence, except for TGEV#8 and #Sb(+), in which cases numbers refer to the TGEV N gene
plus-strand sequence (Kapke and Brian, 1986). Oligonucleotide numbers in PGEM3Z2477(-) corresponds to plasmid vector sequence.
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Figure 2-1 . Schematic depiction of defective-interfering constructs used to test the cis-requirements for the
genomic 5'-UTR and the partial ORF l a region. A. Evidenced by Northern assay that pDrepl replicates in
helper virus-infected cells whereas pNrep2 does not (*from Chang et al., 1 994). B. p77Drep, containing the 77nt 5'-UTR present on pNrep2 and the 288-nt ORF l a region fused to full-length N gene, does not replicate in
helper virus-infected cells. Likewise, p21 0Nrep containing the 2 1 0-nt genomic 5'-UTR but lacking the 288-nt
partial ORF l a region does not replicate.

To create p77Drep, the 210-nt, 5'UTR of pDrep was precisely replaced with the 77-nt,
5'-UTR of the mRNA N message via recombinant PCR mutagenesis. The ORF la-N
gene fusion remained intact. A replication assay was performed in which human rectal
tumor (HRT} cells were first infected with BCoV helper virus, transfected with mutant
p77Drep transcript, and RNA was extracted at designated time points. p77Drep
transcript was visible only at 1 hour posttransfection (hpt) by Northern analysis and no DI
RNA was visible at 24 and 48 hpt indicating that no replication had taken place (Fig. 21). Passaging of DI RNA mutants with progeny virus was monitored by infecting fresh
HRT cells with the infectious supernatant from 48 hpt and probing for DI RNA in the
replication assay. No DI RNA accumulation was observed at viral passage 1 indicating
that no replicon had been packaged and passaged along with progeny virus. Since the
removal of the 210-nt 5'-UTR resulted in the loss of DI RNA replication in p77Drep, it
was concluded that cis-acting signals are present in the unique 133-nt of the UTR.
Analysis of these cis-acting elements is being further analyzed by S. Raman (Raman,
unpublished results).
To test if the 288-nt partial ORF la region contains cis-acting elements for DI
RNA replication, p21ONrep was created. PCR mutagenesis was performed in which the
entire 288-nt of the partial ORF la region was removed, leaving the full-length 210-nt,
5 '-UTR fused to the full-length N gene. In this, a known cis-acting element, stem loop
IV, mapping between nts 186 and 215 that includes the AUG start codon at base 211, was
fully restored based on M-fold predictions. This happened since the first 5-nt of the N
gene correspond identically to the first 5-nt of the partial ORF la region. When HRT
cells were infected with BCoV and transfected with p210Nrep transcripts in a replication
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assay, no evidence for DI RNA replication was observed at 24 or 48 hpt. Also, no
packaged DI RNA was observed at viral passage 1. From these results, it was concluded
that the 288-nt partial ORF la region contains cis-acting elements for BCoV DI RNA
replication.

Premature termination of partial ORF la translation resulted in loss of BCoV DI
RNA replication.

To test whether translation of the entire 288-nt ORF 1a region is required for
BCoV DI RNA replication, individual stop codons were placed throughout the partial
ORF la region and tested. In construct p211AUG ➔ UGA, a UGA stop codon was
introduced at the start codon site (base 211) of the partial ORF la region (Fig. 2-2) by
PCR mutagenesis. At 1 hpt in the replication assay, p211AUG ➔ UGA transcript was
detected by Northern analysis, but at 24 and 48 hpt RNA was undetectable indicating
little or no replication had taken place. No DI RNA was detected at viral passage 1 and
only extremely low amounts were detected at viral passage 2 leading to the conclusion
that DI RNA replication had been severely impaired when a stop (UGA) codon replaced
the start codon of the partial ORF la domain.
In construct p211AUG ➔ UUG the start codon of the partial ORF la region was
mutated to a leucine (UUG) codon (Fig. 2-2). While the transcript of p211AUG ➔ UUG
was clearly visible at 1 hpt, only a slight amount was observed at 24 hpt and no band was
visible at 48 hpt. No DI RNA was detected at viral passages 1 and 2. A repeat of the
replication assay and Northern analysis for p211AUG ➔UUG showed a very faint band at
22
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Figure 2-2. Non-start codon insertions and effects on RNA replication. A. Schematic
depiction of RNA sequence in the 288-nt partial ORF la region, showing stem-loops
IV (Raman, unpublished) and VII. Potential stem-loops V and VI are not depicted
here. B. Non-start codon insertion sites in the partial ORF 1a region and affects on
replication as assayed by Northern analysis.
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virus passage 1 after long exposure to film. Reverse transcription-PCR and DNA
sequencing analysis on RNA extracted from virus passage 1 showed that the UUG
mutation had not been maintained. The DI RNA visible in the faint band at viral passage
1 was, in fact, a revertant containing the wild-type AUG start codon. It was therefore
concluded that a mutation of the partial ORF la start codon to UUG, even though a non
stop codon, caused significantly impaired replication of DI RNA.
Likewise, severe impairment ofDI RNA replication was observed in mutant'
p226AAA ➔ UAA, in which the lysine (AAA) codon, located 15 nt into the open reading
frame, was mutated to a UAA stop codon and in construct p268AUG➔ UGA in which an
internal methionine AUG codon, located 78 nt into the parital ORF 1a open region, was
replaced with a UGA stop codon (Fig. 2-2).
In construct, p468AUA ➔ AM, a 2-nt deletion created at the Bg!II site at nt 468
resulted in a frameshift that created a UAA stop codon at nt 471 which was also lethal for
replication (Fig. 2-2).
Thus, the observed loss of DI RNA replication by the insertion of stop codons at
nt 211, 226, 268,and 471 led to the conclusion that there is a cis-acting requirement of
translation for BCoV DI RNA replication. It is not clear from these experiments whether
the requirement is for the synthesis of a cis-acting protein or for the mere act of
translation itself.

In vitro translation assays verify premature termination of translation in mutant
BCoV DI RNA constructs.

24

To verify that the stop codons created in p211AUG➔ UGA, p211AUG ➔ UUG,
p225AAA ➔ UAA, p268AUG➔ UGA and p468AUA ➔ AM lead to premature
termination of translation, in vitro translation reactions were performed with the
transcripts of each mutant in both wheat germ and rabbit reticulocyte lysates and the sizes
of the products were determined. Previous work by R.Y. Chang (1996) had demonstrated
that translation of the N gene was a cis-acting requirement for BCoV DI RNA
replication. In vitro translation of wild-type pDrep in rabbit reticulocyte lysate revealed
two major translation products, one of approximately 66kDa corresponding in size to the
pDrep-encoded partial ORF l a-N gene fusion protein and one of approximately 50 kDa
corresponding in size to the N protein alone. Three additional minor products were
observed that migrated between the two major bands (data not shown). It is possible that
these represent products of translation initiating at AUG positions 268, 385, and 454.
This would happen if ribosomes had scanned through the start codon at 211. Similar in
vitro translation results for pDrep were observed in reactions performed in wheat germ

lysate (data not shown).
As expected, no full size ORF l a-N fusion translation product was observed from
in vitro translation of p268AUG ➔ UGA in rabbit reticulocyte lysate, although a product

the size of N alone was found indicating a potential scanning to the start site ofN.
Interestingly, three additional bands indicating potential translation starting from one of
three non-start methionines within the internal coding region of partial ORF 1a were
found (data not shown).
In in vitro translation in rabbit reticulocyte lysate ofp211AUG➔ UUG revealed a
minor translation product which could have resulted from the use ofUUG as a weak start
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codon. The ability of UUG to serve as a weak start codon has been observed (Donahue
and Cigan, 1988; Coleman and Raetz, 1988; Coderre and Earhart, 1989; Mauch et al.,
1990; Lahue and Matson, 1990; Yoon and Donahue, 1992; Tolner et al., 1995; Sussman
et al., 1996; Thurlow et al., 1997; Huang et al., 1997; Yeh et al. , 1997; Ghrist and

Stauffer, 1998; Hirose et al., 1999; Nett et al. , 2001). Curiously, in this construct the N
protein alone became the most abundant translation product. In vitro translation in wheat
germ lysate showed similar results. Also, for reasons we cannot explain, in vitro
translation of p211AUG ➔ UGA which should not have allowed ribosomal translation to
commence at start codon nt 211, did show abundant quantities of the full length ORF 1a
N fusion protein (data not shown).
Since N protein synthesis in vitro as evidenced by strong bands of the appropriate
size remains efficient in all mutants, it would seem that any cis-acting requirement for N
should be fulfilled if N protein synthesis from these constructs is efficient in vivo as well.
It is clear, however, that these mutants do not replicate, and this leads us to conclude that
some aspect of ORF 1a translation or the ORF 1a translation product is required for
BCoV DI RNA replication.

Frameshift mutation analyses within the partial ORF 1 a region suggest a cis-acting
role for the ORF la polypeptide in BCoV DI RNA replication.

In an attempt to answer whether the cis-acting translation requirement of the ORF
1a region is due to the process of translation or to a specific protein product, two
frameshift mutant constructs were generated and tested. In construct pFS@223, a
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frameshift was created by deleting the adenosine at nt position 223 such that a sequence
of 27 amino acids would be changed (Fig. 2-3). In order to maintain the required open
reading frame, a cytosine was inserted by PCR mutagenesis at nt position 304. The
identities of 26 of 27 of the original amino acids (amino acids 5 to 31) were changed by
this frameshift. In the replication assay, there was no evidence that transcripts of
pFS@223 underwent replication by 24 or 48 hpt, or at virus passages 1 or 2 (Fig. 2-3).
In the second construct, pFS@270, a single guanosine was deleted by PCR
mutagenesis at nt position 270 and a cytosine was inserted at nt position 304 resulting in
a change in the identity of a 12 amino acid stretch (aa 20 to 31) (Fig. 2-3). As with
pFS@223, the frameshift in pFS@270 resulted in a lethal mutation.
The results with the two frameshift constructs suggest that the polypeptide
product of the partial ORF la is necesssary for BCoV DI RNA replication. It cannot be
rigorously ruled out at this time, however, that the frameshifting mutations did not alter a
cis-acting RNA structural requirement for replication. Although mfold analyses predict
that there had been no alteration of higher-order RNA structures by these mutations,
subtle higher-order structure changes or even changes in a necessary primary nucleic acid
structure might have taken place. Further testing will be required to rigorously establish
that a cis-acting polypeptide element is important for BCoV DI RNA replication
(discussed further in Chapter N).
DISCUSSION

In experiments presented here it was documented that translation of the 288-nt
partial ORF la region within pDrepl is required for BCoV DI RNA replication. This,
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along with an earlier demonstration that translation of some portion of N gene sequence
is also required for replication (Chang and Brian, 1996), brings to two the number of
elements requiring translation in cis for replication in the BCoV DI RNA. The cis
requirement for partial ORF 1a translation was determined by three experimental
approaches. First, precise removal of the 288-nt partial ORF 1a region resulted in loss of
DI RNA replication. Second, insertion of stop codons throughout the partial ORF la
region leading to premature termination of translation resulted in loss of DI RNA
replication. In vitro translations in both rabbit reticulocyte lysate and wheat germ
verified that premature termination of translation takes place with these constructs.
Third, frameshift mutations that maintained the full length of the fused ORF
demonstrated that the quality of the ORF la product is important for DI RNA replication.
Frameshift experiments that altered 12 or 26 of the 96 total amino acids generated by the
partial ORF la region resulted in complete loss of DI RNA replication.
The requirement for translation of the partial ORF 1a region could be two-fold.
One, translation might be required for synthesis of a cis-acting protein. Loss of DI RNA
replication in two frameshift mutants suggests that some quality in cis of the encoded
partial ORF 1a polypeptide is required for maintaining replication. A second possibility
is that the process of translation, or of ribosomal passage, somehow is a prerequisite for
assembly of the RNA replication complex. These possibilities have been suggested by
Novak and Kirkegaard (1994) in reference to poliovirus replication for which a similar
cis-acting dependence on translation had been found.

The fact that the partial ORF la sequence needs to be translated in cis for DI RNA
replication leads to two broad categories of questions regarding mechanism. 1) The first
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is a set of questions addressing how the cis-translation event functions in the DI RNA.
Given that the DI RNA is an artifactual molecule, that is, it is a fusion product of the two
ends of the large coronavirus genome, the mechanism of how cis-translation pertains to.
ORF 1a may not be directly applicable to the genome. On the other hand, it might serve
the same function in the genome but has undergone adaptation for the DI RNA. We view
the fusion event creating the DI RNA a fortuitous one and that the cis-requirement for
ORF la translation probably functions similarly in the full-length, multi-cistronic
genome.
With regard to the first set of questions, namely, how does a cis-requirement for
ORF la translation function in DI RNA replication, the simplest model that would seem
to apply in one articulated in various forms by those who have studied viruses (and their
cognate D RNAs) that contain only a single open reading frame. That is, the protein made
in cis is presented locally, thus, facilitating assembly of the replication complex. Using
deletion analysis, Novak and Kirkegaard (1994) identified a region of the poliovirus
genome requiring cis translation. A newly synthesized, cis-acting protein was postulated
to interact with the mRNA to identify the template for negative strand synthesis. Perhaps
the cis-acting protein has a strong affinity for its mRNA template, thereby, keeping the
protein localized. Also, if protein stability were limited, cis action by the protein might
be predicted to preferentially occur only with the template from which it was synthesized
(Novak and Kirkegaard, 1994).
Like picomaviruses, Kunjin virus (flavivirus) RNA is translated as a single ORF.
Deletion mutations demonstrated that parts of ns5 sequence could not be complemented
in trans. Kunjin virus requires translation in cis of its N terminal ns5 coding sequence for
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replication. The cis-acting NSS protein was hypothesized to interact with other
nonstructural proteins to initiate formation of the replication complex for negative strand
synthesis (Khromykh et al., 1999).
As with BCoV DI RNA, all four clover yellow mosaic virus (CYMV) D RNA
species were found to consist of an in-frame fusion of the N terminus of ORF 1, the
putative replicase, and the C terminus of the coat protein ORF 5 to form a fused single
ORF. CYMV D RNA accumulation in vivo requires translation of the fusion protein.
Small, in-frame deletions and insertions in the coat protein gene in this case, however,
did not affect D RNA replication suggesting the encoded fusion polypeptide sequence is
insignificant in the replication process (White et al., 1992).
With regard to the second set of questions, namely, how would cis-acting
translation for ORF la function in a multicistronic genome, an explanation might reside
in a circular model for the genome. Conceivably, any of the 16 proteolytically-derived
ORF 1 proteins could remain localized with the genome during translation of ORF1. It
has been widely postulated that replication of plus-strand RNA genomes may require
circularization of the genome through 3' and 5' interactions. If circularization takes
place, then the products of ORF 1 could be localized near the 3'-terminus (the starting
point for minus-strand synthesis and the site for assembly of the RNA replication
complex) soon after synthesis. If N is required in the replication complex after being
synthesized in cis, conceivably, it could be made by an internal ribosomal entry onto the
N ORF (suggested by Chang and Brian, 1996).
Certainly, not all coronavirus DI RNAs exhibit the same degree of dependence on
the cis-acting requirement for translation . For MHV DI RNAs, for example, a
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contiguous ORF within the DI RNA is not a strict requirement for replication, but rather,
there is a "preference" for the ORF in cis. This could mean that the partial ORF 1 a
product may more easily reach the replication complex, or possibly the equivalent
molecule encoded by the viral genome may function in trans. Some large coronavirus DI
RNAs, for example those from TGEV and IBV, are multicistronic and, perhaps, the ORF
la contribution for replication in these mimics a mechanism used by the full-length virus
genome.
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CHAPTER III.
A HIGHER-ORDER CIS-ACTING RNA ELEMENT WITHIN THE PARTIAL
ORF IA REGION AS A REQUIREMENT FOR DEFECTIVE-INTERFERING
RNA REPLICATION IN BOVINE CORONAVIRUS

INTRODUCTION
The 5 'and 3' untranslated regions on the genomes of plus-strand RNA viruses
were once believed to contain all of the necessary cis-acting signals for genome
replication. Recently, it has been discovered that for some viruses, RNA elements within
the internal coding regions are also required in cis for replication (McKnight and Lemon,
1998; Lobert et al., 1999; Goodfellow et al. , 2000; Barrera et al., 1993; Miranda et al.,
1997). Thus, these RNA elements have a dual function, (1) to encode a protein and (2) to
directly participate as a signal for genome replication. Three genera in the family
Picomaviridae, the rhinoviruses, cardioviruses, and enteroviruses, contain a cis-acting

replication element (ere) at various positions in the protein coding region. In each case,
these elements are higher order RNA structures that fit the definition of a stem-loop. The
first internal ere discovered was in human rhinovirus type 14 (HRV-14) (McKnight and
Lemon, 1996). The HRV-14 ere is a 96-nt stem-loop structure located in the VP l coding
sequence (McKnight and Lemon, 1998). With the use of dicistronic constructs, the
investigators were able to dissociate RNA replication from translation and to demonstrate
both the replication and coding functions of this RNA element. Additionally, mutational
analysis demonstrated that the structure functions in the positive strand and not in the
negative strand (McKnight and Lemon, 1998).
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The second and third internal cres to be identified were in Theiler's virus and
mengo virus, both cardioviruses (Lobert et al., 1999). The RNA secondary structure
present in a 130-nt stretch of the VP2 capsid protein structurally resembled the HRV-14
ere but differed in location. A functional exchange of this nt stretch could be made
between Theiler's and mengo viruses. However, exchanges of the HRV-14 ere between
those were not tolerated (Lobert et al., 1999). Site-directed mutagenesis of a conserved
9-nt region in cardioviruses revealed that each nt was important for function in the ere.
Additionally, mutations destabilizing the base paired stem region resulted in loss of
replication whereas a compensatory mutation restoring the stem structure restored wild
type replication (Lobert et al., 1999).
In 2000, a ere mapping within the poliovirus 2C coding region and showing
conservation with a ere in enteroviruses was discovered. This internal ere was 61-nt in
length and contained highly conserved sequences in the base paired stem region but
varied considerably in the loop sequence. Interestingly, addition of a second ere structure
to a mutant containing a disabled ere resulted in restored replication (Goodfellow et al,
2000).

While the locations within the genome and the sizes of the respective cres of
poliovirus and HRV-14 differ, there are several notable similarities. (1) Both ere
structures function in the positive or genome-sense strand. (2) Both structures have an
apparent role in minus strand initiation. (3) Neither structure is position-dependent
within the context of the coding region of the genome (McKnight and Lemon, 1998;
Goodfellow et al. 2000).
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To investigate the possibility that the predicted higher-order RNA structures
mapping within the 288-nt ORF 1a region are cis-acting replication elements (cres) for
DI RNA replicatio�. two sets of experiments were done. First, a series of 3 '-terminal, in
frame deletions within the partial ORF 1a region were constructed to determine what
sequences and thus what potential stem-loops were required for DI RNA replication.
Second, mutagenic analyses were done on the phylogenetically-conserved stem-loop VI
which mapped within the active region of the partial ORF 1a sequence and, thus, showed
a high potential for being a cis-acting element for replication. For this, site-directed
mutagenesis disrupting base pairing of the stem portion was carried out in ways that did
not disrupt the amino acid sequence. Disrupted and restored stems were analyzed for
replication. Both sets of experiments support the notion that stem-loop VI mapping
between nts 308 and 343 is a ere, very similar in function to the cres described in
picomavirus genomes. This is the first report of a ere in coronavirus mapping within a
protein-coding region.
MATERIALS AND METHODS

Virus and cells.

Bovine coronavirus Mebus strain was plaque-purified three times and used as
helper virus in all replication experiments. Stock preparations had an infectious titer of 1
x 107 PFU/ml. The human rectal tumor cell line, HRT-18, was used in all experiments.
Cells were grown as monolayers in Dulbecco's modified Eagle medium containing 10%
fetal calf serum (Atlanta Biological, Atlanta, GA) in 35 mm2 plates.
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Construction of plasmids.

Using the indicated DNA template and respective oligonucleotides designated
below and in Table 3-1, the following constructs were made via overlap PCR
mutagenesis, followed by recombination PCR. All PCR mutagenesis reactions were
performed under the same conditions: lX Pfu Turbo enzyme buffer, 0.2mM dNTPs, 25ng
of respective DNA template, 0.5µM of each of respective primer (+) and primer (-) and
l.25U (0.5µ1) Pfu Turbo enzyme (Stratagene), plus water for a final volume of 50µ1.
Initial denaturation was performed at 94° C for 2 minutes. Denaturation, annealing and
extension conditions were 94 ° C, 55 ° C, and 72 ° C, respectively. All temperatures were
maintained for 1 minute each for a total of 13 cycles. Final renaturation was performed
at 72 ° C for 10 minutes.
Recombination PCR was performed using the two products generated during PCR
mutagenesis. In preparation for recombination PCR, PCR products were either excised
from a TAE gel and genecleaned or directly removed via pipette from the TBE gel. For
maximal DNA production, du_e to a need for further molecular manipulations after
recombination PCR, 3-4 50-µl (total 150-200 µ1) recombination reactions were prepared.
Denaturation, annealing, and extension temperatures were 94 ° C, 60 ° C, and 72 ° C,
respectively, for 2 minutes each in 17 total cycles. Final renaturation was performed at
72 ° C for 10 minutes.
Plasmid constructs were all modifications of pDrep1 (Chang and Brian, 1996)
except as noted. For each, mutated regions were confirmed by sequencing at the UTK
Molecular Biology Resource Facility.
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The 3' deletion constructs were all made by overlap PCR mutagenesis with the
same three primers and one differing mutant oligo. Nstart(-) and oligo 2(+) yielded a
494-nt product. PGEM3Z 2477(-) and varying mutant primers produced PCR products
of various sizes. Recombination PCR with PGEM3Z 2477(-) and oligo 2(+) resulted in
a product of varying sizes according to mutant primer used, of which the Hpal-Xbal
fragment was used to replace the analogous region in pDrepl. p1�478-498 used the
mutant primer 1�478-498(+) and yielded an Hpal-Xbal fragment of 423-nt. p1�454498 used the mutant primer 1�454-498(+) and yielded an Hpal-Xbal fragment of 399nt. p1�442-498 used the mutant primer 1�442-498(+) and yielded an Hpal-Xbal
fragment of 387-nt. p1�424-498 used the mutant primer 1�423-498(+) and yielded an
Hpal-Xbal fragment of 369-nt. p1�397-498 used the mutant primer 1�397-498(+)

and yielded an Hpal-Xbal fragment of 342-nt. p1�358-498 used the mutant primer
1�358-498(+) and yielded an Hpal-Xbal fragment of 302-nt. p1�319-498 used the
mutant primer 1�319-498(+) and yielded an Hpal-Xbal fragment of 264-nt. p1�283498 used the mutant primer lru\283-498(+) and yielded an Hpal-Xbal fragment of 228nt. p1�38-498 used the mutant primer lru\238-498(+) and yielded an Hpal-Xbal
fragment of 183-nt. pl� l7-498 used the mutant primer 1�17-498(+) and yielded an
Hpal-Xbal fragment of 162-nt.

pLeft VI was generated by PCR overlap mutagenesis using the 1051-nt fragment
from a reaction with primers PGEM3Z 2477(-) and Left vi(+) and the 688-nt fragment
from a PCR reaction with Left vi(+) and oligo 2(+). Recombination PCR with PGEM3Z
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2477(-) and oligo 2(+) yielded a 1765-nt product of which the 1158-nt Ndel fragment was
used to replace the analogous region in pDrepl.
pRight VI was generated by PCR overlap mutagenesis using the 1065-nt fragment
from a reaction with primers PGEM3Z 2477(-) and Right vi(+) and the 674-nt fragment
from a PCR reaction with Right vi(+) and oligo 2(+). Recombination PCR with
PGEM3Z 2477(-) and oligo 2(+) yielded a 1765-nt product of which the 1158-nt Ndel
fragment was used to replace the analogous region in pDrepl.
pLtRt VI was generated in an identical manner to construct pLeft VI except that
pRight VI was used as the template in PCR reactions, not pDrep1.

In vitro transcription.

Transcription of plasmid constructs including plaL\217-498, plaL\238-498,
plaL\283-498, plaL\319-498, plaL\358-498, plaL\397-498, plaL\424-498, plaL\442-498,
p1aL\454-498, p1aL\478-498, pLeft VI, pRight VI, and pLtRt VI was performed using T7
RNA polymerase as recommended by Promega. For this, 10µg of Mlul linearized
plasmid DNA was blunt-ended with mung-bean nuclease, and 5µg of linearized, blunt
ended DNA was transcribed with 40 units (U) of T7 RNA polymerase (Promega,
Madison, WI) in a 100µ1 reaction which included supplied transcription buffer, 1 0µg
bovine serum albumin (BSA), 1OmM DTT, 100U RNasin and rNTPs. The transcription
reaction mix was then treated with 5U of RNase-free DNase (Promega, Madison, WI)
and newly synthesized RNA was chromatographed through a Biospin 6 column (Bio
Rad, Melville, NY) and quantitated by spectroscopy.
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Assay for replication: transfection and Northern blot analysis.
HRT cells grown to 50-80% confluency (~106 cells) in 35 mm2 dishes were
infected with BCV at a multiplicity of 10 PFU per cell by incubating cells with the
inoculum at 37° C plus 5% _CO2 for lh. Cells were refed with 2ml Dulbecco's modified
Eagle's medium containing 10% fetal bovine serum and incubated at 37° C plus 5% CO2
for 1-l .5h.
For transfection, each plate of cells was rinsed three times with lX phosphate
buffered saline (PBS). Cells were treated for 10 min at room temperature with 10µg
Lipofectin (Invitrogen Gibco-BRL, Carlsbad, CA), l µg transcript and varying amounts of
l X PBS to make a total volume of 200µ1. Cells were rinsed with 2ml of growth medium
without fetal bovine serum. Cells were then incubated at 37° C with 2ml Dulbecco's
modified Eagle medium containing 10% fetal bovine serum until cytoplasmic RNA
extraction was performed at 1 h, 24 h, and 48 h post transfection (hpt).
For serial passage of progeny virus, cell supernatant was harvested at 48 h post
infection and 500µ1 was used to directly infect cells at 50-80% confluency in 35-mm2
dishes. Cytoplasmic RNA was extracted at 48 hours post infection for analysis.
For cell harvest and RNA extraction, cells were washed three times with Earle's
balanced salt solution at the designated time points. With cells on ice, 500µ1 of lysis
buffer (1 OmM Tris buffer, 1 OmM NaCl, 5mM MgCh , and 1 % NP40) were added to each
plate. Cell debris was pelleted at 9400 rpm for 4 min at 4° C and the remaining RNA in
aqueous solution was treated with proteinase K for 30 minutes at 37° C. After phenol
chloroform extraction, RNA was precipitated from the aqueous phase by adding two
volumes of absolute ethanol. Precipitated RNA was stored at -20 ° C.
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One 35-mm dish yielded approximately lOµg of RNA. For Northern analysis,
2.5µg of RNA was loaded per well in a 1% formaldehyde-containing, agarose gel. RNA
samples for electrophoresis were prepared by pelleting precipitate from 500µ1 of the
RNA-ethanol suspension. The RNA pellet was resuspended in a sample mixture
composed of 1.9µ1 lOX morpholinopropane sulfonic acid (MOPS) buffer, 3.3µ1 37%
formaldehyde, 9.3µ1 100% foramide, and water. Loading buffer was added after samples
were heated for 10 min at 65° C. lng of transcript for each construct was prepared and
loaded as a size marker. The gel was loaded, covered in a lX MOPS-formaldehyde
buffer, and electrophoresed at 150 V for 3.5-4.5 h.

32P-radiolabeled

nucleotide probes

were prepared as described (Sethna et al. 1989). The specific activities of the probes
ranged from lx106 to 4x107 cpm/pmole and film exposure times ranged from 24 hours to
7 days.
Electrophoresed RNA was blotted onto nylon membrane (Amersham Biosciences,
Piscataway, NJ) by vacuum transfer in 20X SSC buffer. After a 3h transfer, RNA was
crosslinked on the membrane by ultraviolet radiation. The membrane was prehybridized
in 10ml prehybridization buffer for 6+ h at 55° C in a rotisserie oven. 32P-end labeled
oligonucleotide TGEV 8 (+) was used as the probe for Northern analysis (Hofmann et al.,
1990). The membranes were washed in 2X SSC containing 10% SDS for 20 min at room
temperature and 25 min at 55° C before drying and exposure to film.

40

Synthetic oligonucleotides.

Oligonucleotides used in this study are described in Table 3-1. Oligonucleotides
were synthesized by Sigma-Genosys {The Woodlands, TX) or Invitrogen Gibco-BRL
(Carlsbad, CA).

RNA secondary structure modeling.

Computer-assisted RNA secondary structure modeling was performed using
mfold version 3. 1 at http://bioinfo.math.mi.edu/-mfold/ma/forml .cgi (Zuker et al. , 1999;

Mathews et al. , 1999).
RESULTS

Deletion of 102-nt, but not 141-nt, from the 3'-terminus of the 288-nt ORF la region
is tolerated for DI RNA replication.

It has been previously shown that the 288-nt ORF la region of cloned BCoV DI
RNA (pDrep l ) cannot be removed without loss of replicating ability (Chapter II). To
determine what portion of the partial ORF l a sequence is required for DI RNA
replication, 3 ' terminal in-frame deletions were prepared and tested for replication.
Deletion constructs were created by recombinant PCR and transcripts of each were
transfected into helper virus infected human rectal tumor (HRT) cells and assayed by
Northern analysis for accumulation. Accumulation was regarded as evidence for
replication. Figure 3-1 illustrates that whereas replication could be demonstrated for
transcripts of pl aA478-498, p l aA454-498, pl aA442-498, pl aA424-498, and p l aA397-
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Table 3-1. Oligonucleotides used in this study.
Oligonucleotide•

NSTART(-)

.,::.
N

18l1217-498(+)
18l1238-498(+)
18l1283-498(+)
18l13 19-498(+)
18l1358-498(+)
18l1397-498(+)
18l1409-498(+)
18l1424-498(+)
18l1442-498(+)
18l1478-498(+)
PGEM3Z 2477(-)
Oligo 2(+)
Left vi(-)
Left vi(+)
Right vi(-)
Right vi(+)

TGEV#8(+)
TGEV#8b(+)

Leader (-)
UTRl l1-129(-)

BCV 5'Nt'j

S!:9uence,;

ATGTC1TTTACTCCTGGTAAGC
GAGTAAAAGACAT/CGACATTGTG
GAGTAAAAGACAT/GAGACCGTATTTG
GTAAAAGACAT/TGCGTCCTCACGCAGGAG
GAGTAAAAGACAT/CACCTCTGAAC
GAGTAAAAGACAT/TGTTTCCAGC
GAGTAAAACACAT/ACAATCCACCATC
GAGTAAAAGACAT/AAGAAGTCGGC
GCTTACCAGGAGTAAAAGACAT/ACAACACTCTTG
GCTTACCAGGAGTAAAAGACAT/TATTAGGCTAG
GCTTACCAGGAGTAAAAGACAT/CAAATCATATGGAC
GGCATCAGAGCAGATTGTACTG
GTCCCGATCGAGAATGTCAGCCGGGG
GTAGTTCAGAAGTCGATATAGTATG
CATACTATATCGACTICTGAACTAC
GATATAGTATGCTCGACIACTGCGC
GCGCAGIAGTCGAGCATACTATATC
CATGGCACCATCCTTGGCAACCCAGA
CATGGCACCATCCTTGGCA
GAGCGATTTGCGTGCGTGCATCCCGC
CGTAGATTTTTCATAGTGG
CTAGATTGGTCGGACTGATCGGCCCAC

Binding region (nt positiont
499-520
207-216/499-511
225-237/499-511
274-282/499-509
308-318/499-511
348-357/499-511
384-396/499-511
398-408/499-511
412-423/499-511
431-441/499-511
464-477/499-511
2477-2498
968-993
305-329
305-329
319-343
319-343
1098-1123
1105-1123
7-32
111-129
573-599

Oligonucleotide binds to either plus-sense RNA, as indicated by (+), or to minus-sense RNA, as indicated by (-).
bases indicate differences from genomic sequence.
cNumbers correspond to pDrepl plus-strand sequence, except for TGEV#8(+) and TGEV#Sb(+), in which cases numbers refer to the
TGEV N gene plus-strand sequence (Kapke and Brian, 1 986). Nt numbers in oligonucleotide PGEM3Z24 77(-) correspond to
Promega plasmid vector sequence.
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498, it could not be demonstrated for p1 �358-498, p l ali3 1 9-498, p l ali283-498,
p 1 �23 8-498, or p 1 ali2 l 7-498. Thus, a 3 '-terminal deletion of 1 02-nt but not 141-ht was
tolerated for replication. · 186 nt of 5'-terminal sequence remained in the partial ORF l a
region in a replicating construct. From these experiments it was concluded that the first
1 86 nt of the partial ORF l a region contained cis-acting elements for DI RNA
replication.

Computer-assisted modeling of RNA secondary structures predicted two higher
order RNA structures in the 186-nt shortened partial ORF la region.
With the use of the mfold algorithm developed by Michael Zuker, RNA secondary
structure can be determined from a single RNA sequence (Zuker et al. , 1 999; Mathews et
al., 1 999). Mfold RNA secondary structure predictions for the entire 288-nt ORF l a

region of pDrep 1 yielded three stem-loops of significant thermodynamic stability (Fig. 32). These were named stem-loop V, VI, and VII, corresponding in order to previously
identified RNA stem-loop structures located in the leader and 5' -UTR sequences of
pDrep 1 (Chang et al., 1 994; Chang et al., 1996; Raman, unpublished).
The 5'-most RNA stem-loop in the 288-nt ORF l a region, stem-loop V, is located
at nt 23 1 to 280 and has a calculated free energy of-1 5.9 kcaVmol (Fig. 3-2). It displays
some regions of nucleotide sequence conservation with other group II coronaviruses but
has not investigated further.
Stem-loop VI, located at nt 308 to 343, has a calculated free energy of-1 2.3
kcaVmol. Within it exist three base-paired regions, two bulges, and a terminal loop of
1 0-nt (fig. 3-2). Stem-loop VI appears partially conserved among group II coronaviruses
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by mfold predictions. Stem-loop VI for human enteric coronavirus-4408, human
respiratory coronavirus-OC43, and porcine hemagglutirtating encephalomyelitis virus . .
were the same size as that for BCoV (36-nt), whereas the predicted homologue in mouse
hepatitis virus A59 and equine coronaviruses were smaller (1 7-nt and 1 5-nt,
respectively). Interestingly, the terminal loop among the group II coronaviruses displays
much nucleotide sequence variation. The highest nucleotide sequence conservation is
found among nucleotides making up the base of stem VI (Fig. 3-2).
Stem-loop VII is located at nts 378 through 446 and has a calculated free energy
of -26.5 kcal/mol (Fig. 3-2). Of the three stem-loops, stem-loop VII is overall the most
highly conserved in sequence and structure among the group II coronaviruses. Within its
69 nts there are found six base paired regions, 5 bulges, and a 4-nt terminal loop (Fig. 32). Interestingly, none of the terminal loops are conserved in sequence among the group
II coronaviruses. Inasmuch as three-quarters of stem-loop VII maps within the 3 ' terminal 1 02 nts that can be deleted without loss of DI RNA replication. No further
studies were carried out on stem-loop VII. Thus, from the results of deletion analyses it
was concluded that cis-acting features for replication of pDrep 1 RNA may reside in stem
loops V and VI, or some other yet to be determined structure.

Functional analysis of stem-loop VI demonstrated a cis-acting role in DI RNA
replication.

To test the role of stem-loop VI in DI RNA replication, base substitutions were
introduced that were predicted to disrupt the positive-sense stem-loop structure while
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preserving the wild-type amino acid sequence. For this, mutations were necessarily
restricted to the third nucleotide, or "wobble'' position, in the codons. In construct pLeft
VI, the base substitutions were made in the left side of stem VI and were 315G ➔ A and
318G ➔ C (Fig. 3-3). Structure predictions by the mfold algorithm indicated that these
mutations together would severely disrupt base pairing and lead to a disruption of the
entire stem structure. When transcripts of pLeft VI were tested in a replication assay, no
replication was observed (Fig. 3-3). Additionally, no DI RNA accumulation was
detected at viral passages 1 or 2. Thus, DI RNA replication was impaired when the
structure of stem-loop VI was disrupted by mutations in the left arm. In construct pRight
VI, the base substitutions 333C ➔ G and 336C ➔T were made which were predicted to
disrupt stem.structure but at the same time maintain the wild-type amino acid sequence.
As with, pLeft VI, no replication was observed as noted by the absence of accumulation
at 24 and 48 hpt and after viral passages 1 and 2 (Fig. 3-3).
By combining the mutations in pLeft VI and pRight VI, mutant pLtRt VI was
created in which it was predicted by the mfold program that the stem of stem-loop VI
would be restored. The wild-type amino acid sequence was maintained in pLtRt VI.
When transcripts of pLtRt VI were tested for replication, accumulation was observed at
24 and 48 hpt, but less than at wild-type levels (Fig. 3-3). At viral passages 1 and 2,
replication of pLtRt VI appeared robust. From these results it was concluded that stem
loop VI is a cis-acting element required for DI RNA replication.
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DISCUSSION

In experiments presented here we show evidence for a novel RNA cis-acting
replication element mapping within the first 186-nt region of ORF 1a. We demonstrate
that it is required for BCoV DI RNA replication. First, a deletion analysis that
maintained a single contiguous ORF in every construct revealed that only the 5 '-terminal
186-nt of the 288-nt ORF l a region is needed for DI RNA replication. Second,
computer-assisted RNA folding analysis by the mfold algorithm predicted formation of a
phylogenetically conserved stem-loop VI located at nts 308-343. Third, mutations
predicted to disrupt the stem of stem-loop VI while at the same time maintaining the
wild-type amino acid sequence destroyed replicating ability. Compensatory mutations
. that were predicted to restore secondary structure also restored replicating ability. This is
the first evidence of a higher-order cis-acting replication element mapping within the
coding region of a coronavirus.
Cis-acting, higher-order RNA structural elements mapping within a protein
coding sequence are a relatively recently discovered phenomenon in eukaryotic plus
strand RNA viruses. To date, cis-acting RNA elements with these properties have been
described in only the picornaviruses HRV-14, Theiler's virus, mengo virus, and
poliovirus. In the prokaryotic bacteriophage QP a structure having these properties has
also been described (Barrera et al., 1993; Miranda et al. , 1997).
How might these cis-acting elements function? (1) In bacteriophage QP the
internal ere has been demonstrated to be the nucleation site for the assembly of the
replicase complex. A tertiary RNA structure brings together the S-site and the M-site to
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create a protein-binding domain for its viral RNA polymerase and host cell proteins.
Thus, RNA plus-strand template recognition for minus-strand synthesis is achieved
(Miranda et al., 1 997). (2) In the three picomavirus genera, rhinovirus, cardiovirus,- and
enterovirus, all three higher order cis-acting replication elements (ere) form on the
positive-strand RNA. Additionally, human rhinovirus type 14 (HRV- 14) and poliovirus
ere mutants that result in loss of RNA replication occur because of impaired initiation of
minus-strand synthesis. Since they are on the genome-sense strand, these RNA structures
are hypothesized to function as recognition sites or binding sites for viral and/or cellular
proteins involved in RNA replication. Consequently, functional loss of these ere
elements results in loss of minus-strand synthesis (McKnight and Lemon, 1 998)
(Goodfellow et al. , 2000) (Lobert et al., 1999). Further experimentation is needed to
determine how stem-loop VI in BCo V DI RNA functions mechanistically (discussed in
Chapter IV).
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CHAPTER IV.
CONCLUSIONS AND FUTURE DIRECTIONS

This study describes the discovery of two cis-acting elements mapping within the
288-nt partial ORF 1 a region in BCoV DI RNA replication. Two broad categories of
analysis are proposed for the future study. The· first is a more precise characterization of
the respective elements described in Chapters II and III and an analysis of stem-loop V
that has not yet been characterized at all. The work in this study was largely one of
documenting of the existence of the cis-acting protein and RNA stem-loop VI. The
second category is a determination of the actual roles of these elements in RNA
replication.
Regarding the cis-acting ORF l a polypeptide, the following should be done. 1) It
should be confirmed that the ORF 1 a frameshift mutations have not introduced undesired
stop codons. This could be done by in vitro translation analyses using the mutant
transcripts and the methods described in Chapter II. 2) The cis-acting protein should be
compared with known functional protein motifs and those motifs associated with post
translational modifications. This could be done by computer searches. 3) The proteins
should be localized in infected cells. Recent biochemical and fluorescent microscope
studies have proven successful in determining where the various cleavage protein
products of mouse hepatitis coronavirus ORF 1 a and 1 b polyprotein localize in infected
cells. These results provide clues as to where and how the proteins might function.
MHV p28, the full-length homologue of the partial ORF l a polypeptide located in
pDrepl , has been shown to localize with replication complexes and sites of RNA
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synthesis (Denison et al. , 1 999; Bost et al. 2000). More information about the
localization of the partial ORF l a-N fusion encoded by BCoV pDrep l might provide
insight into its function.
Regarding the cis-acting stem-loop VI, precisely what features in its structure are
required for its function? This question requires a more rigorous characterization of its
structure. For this, enzyme structure probing in which specific single-stranded and
double-stranded RNases are used to map base paired and looped regions should be done.
While mfold predictions and phylogenic comparisons suggests the presence of stem-loop
VI, biochemical data proving its actual structure would aid in the interpretation our
mutagenesis data presented in Chapter Ill. Additionally, enzyme probing would confirm
or rule out the existence of stem-loop VI on positive-sense RNA.
Further characterization of stem-loop VI would also address questions regarding
its dependence on position for function. Studies with cis-acting replication elements (ere)
in poliovirus and human rhinovirus- 14 (HRV- 14) genomes demonstrate that these stem
loop structures can function in a position-independent manner within their respective
coding regions (McKnight and Lemon, 1 998; Goodfellow et al. , 2000). Also, in .
poliovirus it was demonstrated with replicons containing a single, mutated, non
functional ere that RNA replication could be restored upon addition of a second, wild
type internal ere (Goodfellow et al., 2000). Similar questions should be addressed with
stem-loop VI ofpDrep l . Can stem-loop VI function in a position-independent manner as
well? Are there spatial constraints on the position of stem-loop VI requiring a specific
distance from either the 5 ' or 3 '-UTR? Might a mutated, nonfunctional stem-loop VI in
pDrepl be functionally compensated by the addition of a second, wild-type stem-loop VI
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at a different position? These questions can be addressed with the methods employed in
this study.
Regarding the function of stem-loop VI, several aspects should be investigated.
First, it should be determined at which stage in RNA replication stem-loop VI is required.
It has been shown with HRV- 14 and poliovirus ere elements that they are involved in the
initiation of minus-strand RNA synthesis (McKnight and Lemon, 1998; Goodfellow et
al. , 2000). For this, the ribonuclease protection assay was used for detection of newly

synthesized minus-strand RNA (McKnight and Lemon, 1998; Goodfellow et al. , 2000)
and could be similarly employed for investigating whether BCoV stem-loop VI mutations
affect minus or plus-strand RNA synthesis. Second, the electrophoretic mobility shift
assay should be used to determine whether a viral or cellular protein(s) binds to stem
loop VI. The mutants studied in the replication assay above could be used in the binding
assay. It is predicted that protein that would bind to the wild-type structure would not
bind to the mutated structure. Third, the potential for long range, tertiary interactions of
stem-loop VI with other RNA structures should be investigated. Fourth, it should be
determined whether the phylogenetic conservation in structure of stem-loop VI in group 2
coronaviruses reflects a conservation in function. It was demonstrated with the related
Theiler's and mengo enteroviruses that internal ere structures could be functionally
exchanged in chimeric molecules. However, the HRV-14 internal ere could not be
functionally exchanged with Theiler's virus (Lobert et al. , 1999). Can BCoV stem-loop
VI be functionally exchanged with homologous regions in other group 1, 2, or 3
coronaviruses? Synthesis of chimeric molecules tested in the in vivo replication assay
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should answer these questions.
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